Milan-based Demetra Holding acquires a 51% stake in GetSet Surgical, a leader in sterile packaged single-use spine surgical kits founded in 2016. The strategic acquisition will enhance Demetra’s infection management solutions and orthopedic offerings.

米兰的Demetra Holding收购了GetSet Surgical 51%的股份，GetSet Surgical是一家成立于2016年的无菌包装一次性脊柱手术套件的领军企业。此次战略性收购将加强Demetra的感染管理解决方案和骨科产品供应。

Demetra Holding

德墨忒尔控股公司

, an innovative and independent international medical company providing anti-infective cements, spacers and biomaterials for orthopedic applications, today announced its acquisition of a 51% stake in GetSet Surgical, a leading Swiss-based spine surgical solutions provider.

，一家创新且独立的国际医疗公司，提供用于骨科应用的抗感染水泥、间隔物和生物材料，今天宣布收购了总部位于瑞士的领先脊柱手术解决方案提供商GetSet Surgical 51%的股份。

Biopôle-based

基于生物圈的

GetSet Surgical

获取设置外科手术

is transforming conventional spine surgery practices by providing sterile-packed, ready-to-use implants and instruments. The use of sterile-packaged disposable implants and instruments helps to reduce the risk of infections and hospital costs associated with central sterilization issues, aligning directly with Demetra’s mission of becoming the company of choice for infection management and efficiency through its portfolio companies: Tecres, OSARTIS, OsteoRemedies and Yijiutai..

通过提供无菌包装、即用型植入物和器械，正在转变传统的脊柱外科手术实践。使用无菌包装的一次性植入物和器械有助于降低与中心灭菌问题相关的感染风险和医院成本，这直接符合德米特拉公司通过其旗下公司Tecres、OSARTIS、OsteoRemedies和义久泰成为感染管理和效率方面首选公司的使命。

Global expansion and US market focus

全球扩张与美国市场聚焦

As part of its expansion plans, Demetra Holding is prioritizing the introduction of GetSet’s products into the United States market. The newly established US Spine Division of Demetra’s portfolio company OsteoRemedies will manage the distribution of these products. This division will be headed by Ted Bird, an industry veteran recently appointed Vice President Spine Commercial..

作为其扩张计划的一部分，德米特拉控股公司正优先将GetSet的产品引入美国市场。德米特拉旗下子公司OsteoRemedies新成立的美国脊柱部门将负责这些产品的分销。该部门将由最近被任命为脊柱商业副总裁的行业资深人士泰德·伯德领导。

The initial US product offerings will include GetSet’s GoPLF! Posterior Lateral Fusion system, already FDA approved. Introduction of GetSet's GoLIF! Lumbar Interbody Fusion system is anticipated to take place later this year following FDA 510(k) clearance which is pending. Additional systems already in development will be expedited by this new investment..

美国最初的产品供应将包括GetSet的GoPLF！后外侧融合系统，该系统已获得FDA批准。预计GetSet的GoLIF！腰椎间融合系统将在今年晚些时候推出，等待FDA 510(k)许可。这笔新投资将加快已在开发中的其他系统的进程。

Integration into Demetra's global infrastructure

融入Demetra的全球基础设施

Beyond the US, Demetra Holding is committed to expanding GetSet Surgical’s innovative products across its global operations. Both the GoPLF! and GoLIF! systems are already CE-marked and available for distribution in European and other international markets. By leveraging Demetra’s extensive infrastructure, the integration of GetSet Surgical will expand the availability of advanced healthcare solutions in key global markets, with a focus on improving patient outcomes and driving efficiency in healthcare delivery worldwide..

除了美国，Demetra Holding 致力于在全球业务中扩展 GetSet Surgical 的创新产品。GoPLF! 和 GoLIF! 系统均已获得 CE 认证，并已在欧洲及其他国际市场上市销售。通过利用 Demetra 遍布全球的基础设施，GetSet Surgical 的整合将进一步扩大先进医疗解决方案在关键全球市场的可用性，重点在于改善患者治疗效果并提升全球医疗交付的效率。

Michele Perrino, CEO of Demetra Holding, commented: “Demetra Holding is proud to spearhead this collaboration, as it aligns perfectly with our mission to enhance healthcare solutions focused on orthopedic infection management strategies worldwide. By combining the innovative capabilities of GetSet Surgical with our existing product offerings, we are striving to create and become the premier choice for surgeons and their patients in the single-use, sterile packaged spinal procedure market.”.

米凯莱·佩里诺，德墨忒尔控股公司首席执行官评论道：“德墨忒尔控股公司很荣幸能够带头开展这项合作，因为这与我们提升全球骨科感染管理策略医疗解决方案的使命完全契合。通过将GetSet Surgical的创新能力与我们现有的产品相结合，我们正努力在一次性使用的无菌包装脊柱手术市场中成为外科医生及其患者的首选。”

Ole Stoklund, founder and CEO of GetSet Surgical stated: “The integration of GetSet’s cutting-edge sterile packaged spine procedure kits with Demetra Holding’s robust portfolio and resources will significantly enhance our mutual commitment to minimizing infection risks and optimizing operational efficiencies in hospitals and the emerging ASC market.”.

GetSet Surgical的创始人兼首席执行官奥勒·斯托克隆德表示：“将GetSet先进的无菌包装脊柱手术套件与Demetra Holding强大的产品组合和资源相结合，将显著加强我们双方对降低感染风险和优化医院及新兴ASC市场运营效率的共同承诺。”

(Press release / SK)

（新闻稿 / SK）

0

0

Comments

评论

Back to all news

返回所有新闻

Please

请

login

登录

or

或

sign up

注册

to comment.

评论。

Commenting guidelines

评论指南

Send

发送